BR9812472A - Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado - Google Patents

Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado

Info

Publication number
BR9812472A
BR9812472A BR9812472-2A BR9812472A BR9812472A BR 9812472 A BR9812472 A BR 9812472A BR 9812472 A BR9812472 A BR 9812472A BR 9812472 A BR9812472 A BR 9812472A
Authority
BR
Brazil
Prior art keywords
mamaglobin
tumor
mammaglobin
patient
isolated
Prior art date
Application number
BR9812472-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Mark A Watson
Timothy P Fleming
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of BR9812472A publication Critical patent/BR9812472A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9812472-2A 1997-09-18 1998-09-18 Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado BR9812472A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/933,149 US5922836A (en) 1995-05-31 1997-09-18 Mammaglobin antigens
PCT/US1998/017991 WO1999014230A1 (en) 1997-09-18 1998-09-18 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (1)

Publication Number Publication Date
BR9812472A true BR9812472A (pt) 2000-09-19

Family

ID=25463453

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812472-2A BR9812472A (pt) 1997-09-18 1998-09-18 Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado

Country Status (16)

Country Link
US (1) US5922836A (enExample)
EP (1) EP1037901A4 (enExample)
JP (1) JP2001516569A (enExample)
KR (1) KR20010030617A (enExample)
CN (1) CN1277614A (enExample)
AU (1) AU735338B2 (enExample)
BR (1) BR9812472A (enExample)
CA (1) CA2304167A1 (enExample)
HU (1) HUP0004022A2 (enExample)
IL (1) IL134998A0 (enExample)
NO (1) NO20001358L (enExample)
NZ (1) NZ503729A (enExample)
PL (1) PL340689A1 (enExample)
TR (2) TR200003685T1 (enExample)
WO (1) WO1999014230A1 (enExample)
ZA (1) ZA988526B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6471660B1 (en) 1999-01-21 2002-10-29 Chandice Covington Method and apparatus for measuring factors in mammary fluids
AU4469400A (en) * 1999-04-20 2000-11-02 Zymogenetics Inc. Zalpha13: a human secreted protein
WO2000073338A1 (en) * 1999-05-28 2000-12-07 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
AU5638400A (en) * 1999-06-23 2001-01-09 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
CA2392510A1 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6489101B1 (en) 1999-11-30 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2001236911A1 (en) * 2000-02-11 2001-08-20 Corixa Corporation Lipophilin complexes for use in cancer diagnosis and therapy
JP2004505611A (ja) * 2000-04-03 2004-02-26 コリクサ　コーポレイション 乳癌の検出およびモニタリングのための方法、組成物、およびキット
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
AU2008279584A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
KR101603400B1 (ko) * 2014-02-04 2016-03-14 경상대학교산학협력단 맘마글로빈을 포함하는 암전이 억제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US573916A (en) * 1896-12-29 Threshing-machine
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) * 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast

Also Published As

Publication number Publication date
AU9373798A (en) 1999-04-05
NZ503729A (en) 2001-12-21
EP1037901A4 (en) 2003-07-16
NO20001358L (no) 2000-05-12
US5922836A (en) 1999-07-13
TR200001646T2 (tr) 2000-10-23
PL340689A1 (en) 2001-02-26
EP1037901A1 (en) 2000-09-27
TR200003685T1 (tr) 2001-04-20
HUP0004022A2 (en) 2001-03-28
IL134998A0 (en) 2001-05-20
NO20001358D0 (no) 2000-03-15
WO1999014230A1 (en) 1999-03-25
CN1277614A (zh) 2000-12-20
CA2304167A1 (en) 1999-03-25
AU735338B2 (en) 2001-07-05
ZA988526B (en) 1999-08-16
JP2001516569A (ja) 2001-10-02
KR20010030617A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
BR9812472A (pt) Vacina especìfica de mamaglobina, processo para tratar um paciente com um tumor que expressa mamaglobina, e, polipeptìdeo isolado e purificado
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
BR0113491A (pt) Polinucleotìdeo e polipeptìdeo isolados, vetor de expressão, célula hospedeira, proteìna de fusão, métodos para estimular e/ou expandir células t especìficas para uma protéina de tumor, para estimular uma resposta imune em um paciente, para o tratamento de um câncer em um paciente e para inibir o desenvolvimento de um câncer em um paciente, população de célula t isolada, composição, e, uso de um componente.
ATE267258T1 (de) Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
NO20013701D0 (no) HER-2/neu-fusjonsproteiner
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
DE68924162D1 (de) Stressproteine und verwendungen dafür.
AR032743A1 (es) Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon
ATE389712T1 (de) Krebs immuntherapie mit semi-allogenen zellen
ES8600215A1 (es) Un procedimiento para preparar un oligopeptidos antigenico
EE200100203A (et) Meetod immuunvastuse indutseerimiseks polüpeptiidse antigeeni vastu ja rakuga seotud polüpeptiidse antigeeni mahasurumiseks loomorganismil, selle meetodi kasutamine eesnäärme- ja rinnavähi raviks ning immunogeenne kompositsioon
BR9712988A (pt) Imunoterapia do câncer usando células tumorais combinadas com mistura de linfócitos
PL343245A1 (en) Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
DE60038567D1 (de) Modifiziertes gp100 und dessen verwendung
WO2003033520A3 (en) Anticancer vaccine and diganostic methods and reagents
BR9914161A (pt) Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra
ATE187493T1 (de) Gp75 als tumorimpfstoff gegen melanome
EP1536006A4 (en) CANCER-ANIMALS AND THEIR USE
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
EP0202642A3 (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
BRPI0511624A (pt) anticorpos e moléculas relacionadas que se ligam à proteìnas psca
BR0012446A (pt) Proteìna da rede de leitura alternativa do receptory de células t e uso da mesma
BRPI0409321A (pt) antìgeno hìbrido, competição e método para induzir uma resposta imune para um agente infeccioso ou antìgeno de tumor, método para tratar uma doença infecciosa ou cáncer, e, peptìdeo

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]